Elsa Medical · Global

Technology

Engineering the platforms behind modern aesthetic medicine.

Each Elsa Medical platform is engineered to specification, calibrated against clinical evidence, and held to a single standard — across micro-focused ultrasound, cryolipolysis, vascular laser, and the platforms that follow.

Our approach

Three principles, every platform.

01 · Multi-modality

Platforms across modalities.

We engineer clinical platforms across multiple aesthetic modalities — currently micro-focused ultrasound, cryolipolysis, and vascular laser, with Clinical Skincare in development. Each modality is selected for clinical defensibility, not market trend.

02 · Calibrated delivery

Engineered to specification.

Each platform delivers its modality at precisely calibrated parameters — depth, temperature, timing, duration — for repeatable clinical outcomes across patient populations. The platform is the variable; the patient and the practitioner are not.

03 · Single standard

One clinical standard.

From engineering specification through certified delivery, every platform is held to a single clinical standard. The standard does not vary by provider, by clinic, or by location.

Platform 01 · Micro-Focused Ultrasound

Acoustic energy at calibrated depth.

Our micro-focused ultrasound platform delivers acoustic energy past the epidermis to precisely targeted treatment depths. The targeted thermal stimulus initiates the body's own collagen and elastin remodelling response — a structural change measurable in clinical observation and repeatable across patient populations.

  • Delivery — focused acoustic energy at eight calibrated depths
  • Effect — dermal collagen and SMAS-layer thermal response
  • Surface — non-incisive; no surface disruption
  • Outcome — progressive structural lifting over three to six months
  • Product — delivered through the Ultratherma System
View Ultratherma

Platform 02 · Cryolipolysis

Controlled cooling for subcutaneous adipocyte apoptosis.

Our cryolipolysis platform delivers calibrated cooling to localised treatment zones, inducing apoptosis of subcutaneous adipocytes while sparing surrounding tissue. The body processes treated cells through standard metabolic pathways over the weeks following treatment, producing measurable reduction in localised fat thickness.

  • Delivery — controlled cooling at calibrated temperature and duration
  • Effect — selective apoptosis of subcutaneous adipocytes
  • Surface — preserves dermis, nerves, and surrounding tissue
  • Outcome — progressive reduction over the weeks following treatment
  • Product — delivered through the CoolLipo System
View CoolLipo

Platform 03 · Vascular Laser

Selective photothermolysis for vascular targets.

VascuClear is engineered around selective photothermolysis — calibrated light energy absorbed by oxyhaemoglobin within the targeted vessel, converted to heat to coagulate it, while integrated cooling shields the surrounding skin. The newest energy modality in the Elsa Medical portfolio.

  • Approach — selective photothermolysis, targeting oxyhaemoglobin
  • Wavelengths — dual, calibrated surface to deep
  • Surface — non-incisive; integrated epidermal cooling
  • Network — delivered through Elsa Medical Certified Providers
View VascuClear

Platform 04 · Clinical Skincare

In development.

An additional Elsa Medical clinical platform — focused on Clinical Skincare — is in development. Information will be released upon platform certification.

Updates are published on our News page.

Engineering philosophy

How we engineer the platforms.

Every Elsa Medical platform begins with the engineering — the calibration of delivery, the validation against clinical evidence, the design of the treatment protocol. Patient-selection criteria are built into the platform specification, not bolted on at the clinic.

Provider certification is part of the platform, not a separate sales process. Each practitioner is trained on the system as it was engineered — same parameters, same protocol, same standard.

The result is a clinical standard that does not vary by provider, by location, or by patient. The platform is the same. The protocol is the same. The outcome is repeatable.

For medical professionals

Talk to Elsa Medical.

For enquiries about our clinical platforms, the Certified Provider Programme, or partnership opportunities, get in touch.

Contact us →